Selected article for: "leukemia virus and murine leukemia virus"

Author: Willemsen, Anouk; Zwart, Mark P
Title: On the stability of sequences inserted into viral genomes
  • Document date: 2019_11_14
  • ID: vv5gpldi_69
    Snippet: Besides the risks related to retroviral gene therapy, the limited efficiency of in vivo gene transfer poses another obstacle. Replication defective retrovirus vectors are often used in clinical trials but limited since they can only infect a fraction of solid tumor cells (Rainov and Ren 2003) . For the delivery of the transgene in all tumor cells, replication-competent retroviral vectors are a promising alternative. The suitability of murine leuk.....
    Document: Besides the risks related to retroviral gene therapy, the limited efficiency of in vivo gene transfer poses another obstacle. Replication defective retrovirus vectors are often used in clinical trials but limited since they can only infect a fraction of solid tumor cells (Rainov and Ren 2003) . For the delivery of the transgene in all tumor cells, replication-competent retroviral vectors are a promising alternative. The suitability of murine leukemia virus (MLV)-based vectors for cancer gene therapy has been analyzed in vitro and in vivo by Paar et al. (2007) . They found that the choice of the virus strain, the position of the insert, and the host cells used, can influence the replication kinetics, genomic stability, and transgene expression levels (Paar et al. 2007) .

    Search related documents:
    Co phrase search for related documents
    • cancer gene therapy and vivo gene transfer: 1
    • clinical trial and tumor cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • clinical trial and virus strain: 1, 2
    • gene therapy and virus strain: 1, 2, 3, 4
    • gene therapy and vivo gene transfer: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • gene transfer and virus strain: 1
    • gene transfer and vivo gene transfer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • host cell and virus strain: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • host cell and vivo gene transfer: 1, 2
    • leukemia virus and virus strain: 1, 2, 3, 4, 5
    • murine leukemia virus and virus strain: 1, 2
    • promising alternative and virus strain: 1
    • retroviral gene therapy and vivo gene transfer: 1
    • transgene delivery and virus strain: 1
    • transgene delivery and vivo gene transfer: 1
    • transgene expression and virus strain: 1
    • transgene expression and vivo gene transfer: 1, 2, 3, 4
    • transgene expression level and vivo gene transfer: 1, 2
    • tumor cell and virus strain: 1